Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?
Year-to-date chart of Evoke Pharma stock through early November 2025. Shares were volatile throughout 2025, and the Q4 acquisition announcement triggered a dramatic spike to new highs, bringing the stock roughly back to breakeven for the yeartipranks.com. Evoke Pharma’s stock has experienced extreme volatility in recent weeks. After trading in the mid-$4 to $5 range through October, EVOK plunged 10.9% on November 3, 2025 to $4.59 at the closetipranks.com. The very next day, news of the buyout sent the stock exploding upward – EVOK opened around $10.70 on Nov 4 and closed at $10.77, up roughly +134% in one sessiontipranks.com. In pre-market trading that morning, shares had been up as much as +133%tipranks.com, signaling the market’s immediate recognition of the lucrative $11/share acquisition price. Volume on Nov 4 exceeded 2.1 million shares, an enormous surge compared to EVOK’s ~29,000 three-month average daily volumetipranks.com. This indicates many traders rushed in upon the news.
